Ferumoxytol is an intravenously administered iron preparation indicated in the EU and the US for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD). It is comprised of superparamagnetic iron oxide nanoparticles which are coated by a semi-synthetic carbohydrate shell in an isotonic, neutral pH solution that may be administered at relatively high dose by rapid intravenous injection. Its therapeutic use is listed as diagnostic agents. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Feraheme, Rienso, Feridex and Endorem. Its PubChem CID is 6432052.
Ferumoxytol
| CAS No | 722492-56-0 |
|---|---|
| Molecular Formula | Fe3O4 |
| Molecular Weight | 231.53 g/mol |
| Synonyms | iron(2+);bis(iron(3+));tetrakis(oxygen(2-)) |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ferumoxytol is an intravenously administered iron preparation indicated in the EU and the US for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD).
The listed CAS number is 722492-56-0.
The listed molecular formula is Fe3O4.
The listed molecular weight is 231.53 g/mol.
iron(2+);bis(iron(3+));tetrakis(oxygen(2-)).
The source lists Feraheme, Rienso, Feridex and Endorem.